Sarepta Therapeutics Inc (NASDAQ:SRPT)’s traded shares stood at 3.74 million during the last session, with the company’s beta value hitting 0.66. At the close of trading, the stock’s price was $38.79, to imply a decrease of -3.15% or -$1.26 in intraday trading. The SRPT share’s 52-week high remains $173.25, putting it -346.64% down since that peak but still an impressive 12.09% since price per share fell to its 52-week low of $34.10.
Analysts have given a consensus recommendation of Buy for Sarepta Therapeutics Inc (SRPT), translating to a mean rating of 1.44. Of 17 analyst(s) looking at the stock, 1 analyst(s) give SRPT a Sell rating. 0 of those analysts rate the stock as Overweight while 6 advise Hold as 10 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 1.27.
Sarepta Therapeutics Inc (NASDAQ:SRPT) trade information
After registering a -3.15% downside in the last session, Sarepta Therapeutics Inc (SRPT) has traded red over the past five days. The 5-day price performance for the stock is 9.98%, and -34.80% over 30 days. With these gigs, the year-to-date price performance is -68.10%.
The extremes give us $110 and $202 for target low and target high price respectively. As such, SRPT has been trading -420.75% off suggested target high and -183.58% from its likely low.
Sarepta Therapeutics Inc (SRPT) estimates and forecasts
The rating firms project that company’s revenue will grow 34.43% compared to the previous financial year.
Revenue forecast for the current quarter as set by 18 analysts is 558.94M. Meanwhile, for the current quarter, a total of 18 analyst(s) estimate revenue growth to 608.35M.Earnings reports from the last fiscal year show that sales brought in 362.93M and 467.17M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 54.01% before jumping 30.22% in the following quarter.
SRPT Dividends
Sarepta Therapeutics Inc has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is VANGUARD GROUP INC with 9.04 million shares, or about 9.5496% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $1.43 billion.
We also have GROWTH FUND OF AMERICA and iShares Trust-iShares Core S&P Mid-Cap ETF as the top two Mutual Funds with the largest holdings of the Sarepta Therapeutics Inc (SRPT) shares. Going by data provided on Mar 31, 2025 , GROWTH FUND OF AMERICA holds roughly 3.15 shares. This is just over 3.21% of the total shares, with a market valuation of $122.19 million. Data from the same date shows that the other fund manager holds a little less at 3.12, or 3.17% of the shares, all valued at about 121.02 million.
